Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CUE | ADAG | GNLX | ||
| Company | Cue Biopharma Inc | Adagene Inc ADR | Genelux Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.07 | 2.54 | 3.95 | ||
| High | 2.26 | 2.54 | 4.11 | ||
| Low | 2.05 | 2.28 | 3.78 | ||
| Last | 2.08 | 2.31 | 3.84 | ||
| Change | -0.05 | -0.10 | +0.01 | ||
| % Change | -2.35% | -4.15% | +0.26% | ||
| Volume | 319,200 | 25,700 | 152,700 | ||
| 20-Day Average Volume | 353,935 | 14,345 | 142,225 | ||
| Previous Close | 2.13 | 2.41 | 3.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.68 | 2.57 | 3.70 | ||
| 20-Day Raw Stochastic | 81.20% | 11.70% | 42.63% | ||
| 20-Day Relative Strength | 57.34% | 41.76% | 39.41% | ||
| Weighted Alpha | -69.85 | -6.98 | -84.32 | ||
| Today's Opinion | 56% Sell | 24% Sell | 88% Sell | ||
| Previous Opinion | 56% Sell | 8% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 64% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +46.48% since 04/29/24 | +2.67% since 04/29/24 | +21.14% since 04/29/24 | ||
| Low | 1.37 on 04/30/24 | 2.23 on 05/01/24 | 3.06 on 04/30/24 | ||
| High | 2.26 on 05/06/24 | 2.58 on 05/03/24 | 4.11 on 05/06/24 | ||
| 1-Month | |||||
| %Chg | +12.43% since 04/05/24 | -18.95% since 04/05/24 | -22.11% since 04/05/24 | ||
| Low | 1.30 on 04/25/24 | 2.20 on 04/29/24 | 3.06 on 04/30/24 | ||
| High | 2.26 on 05/06/24 | 3.14 on 04/10/24 | 5.12 on 04/08/24 | ||
| 3-Month | |||||
| %Chg | -17.13% since 02/06/24 | -32.06% since 02/06/24 | -54.72% since 02/06/24 | ||
| Low | 1.30 on 04/25/24 | 2.20 on 04/29/24 | 3.06 on 04/30/24 | ||
| High | 2.58 on 02/12/24 | 3.80 on 02/09/24 | 9.82 on 02/08/24 | ||
| 6-Month | |||||
| %Chg | -18.43% since 11/06/23 | +71.11% since 11/06/23 | -72.50% since 11/06/23 | ||
| Low | 1.30 on 04/25/24 | 1.31 on 11/08/23 | 3.06 on 04/30/24 | ||
| High | 3.25 on 12/08/23 | 4.38 on 01/26/24 | 16.60 on 12/28/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 103,610 | 106,322 | 102,893 | ||
| Shares Outstanding, K | 48,643 | 44,117 | 26,865 | ||
| Annual Sales | 5,490,000 | 18,110,000 | 170,000 | ||
| Annual Net Income | -50,730,000 | -18,950,000 | -28,300,000 | ||
| Last Quarter Sales | 1,820,000 | 391,413 | 0 | ||
| Last Quarter Net Income | -13,430,000 | -12,767,865 | -6,770,000 | ||
| 60-Month Beta | 1.98 | 0.52 | -1.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 04/08/24 | N/A | -0.25 on 03/29/24 | ||
| Latest Earnings Date | 05/14/24 | 04/02/24 | 04/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||